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Greenlandic Inuit are highly exposed to
persistent organic pollutants (POPs) from their
diet and from the contamination of the Arctic
environment from emissions at lower latitudes
(Deutch and Hansen 2000). Some of the high-
est biologic concentrations of POPs measured
in humans worldwide have been among
Greenlandic Inuit (Danish Environmental
Protection Agency 1997; Dewailly et al. 1999).
There is some evidence from human studies
that exposure to POPs, many of which are
known endocrine disruptors, may increase the
risk of certain cancers, such as non-Hodgkin
lymphoma (Colt et al. 2005; Engel et al. 2007),
pancreatic cancer (Hardell et al. 2007; Hoppin
et al. 2000; Porta et al. 1999), and prostate can-
cer (Ritchie et al. 2003). In addition, POP
exposures have been associated with auto-
immune diseases (Powell et al. 1999), diabetes,
(Longnecker and Daniels 2001), developmen-
tal neurotoxicity (Kakeyama and Tohyama
2003; Seegal 1996; Tilson and Kodavanti
1998; Winneke et al. 2002), and adverse
reproductive end points, such as spontaneous
abortion (Korrick et al. 2001; Longnecker et al.
2005; Venners et al. 2005), birth defects
(Salazar-Garcia et al. 2004), and impaired male
fertility (Cocco et al. 2005; Pﬂieger-Bruss et al.
2004). However, the mechanisms by which
POPs can lead to these diseases and adverse
outcomes are not well characterized. We
hypothesized that POPs may operate at the epi-
genetic level by inﬂuencing chromosomal sta-
bility and gene expression and not by directly
affecting changes in DNA sequence. Aberrant
DNA methylation is an epigenetic mechanism
that has been associated with a wide range of
diseases, including those potentially associated
with exposure to POPs (Balada et al. 2007;
Perrin et al. 2007; Wilson et al. 2007). In par-
ticular, global DNA hypomethylation is gener-
ally associated with chromosomal instability,
reactivation of retrotransposable elements, and
the expression of genes that would normally be
silenced by methylation (Jones and Baylin
2002; Schulz 2006; Smith and Crocitto 1999).
To investigate whether these POPs may
operate at the epigenetic level and to test the
hypothesis that POPs exposure is associated
with global DNA hypomethylation (i.e., an
inverse association with DNA methylation),
we examined the correlation between lifetime
body burden of POPs and percentage of global
genomic DNA methylation, percent 5-methyl-
cytosine (%5-mC), in a highly exposed popu-
lation. Blood specimens had been collected
previously from Greenlandic Inuit (n = 71)and
analyzed for a battery of POPs (Deutch and
Hansen 2000). For this study, DNA was
extracted from the same whole blood samples,
and we investigated global genomic DNA in
repetitive elements Alu and LINE-1 (long
interspersed nucleotide element). Because
there are approximately 1.4 million Alu repeti-
tive elements in the human genome and a half
a million LINE-1 elements (Kazazian and
Goodier 2002; Yang et al. 2004) that are nor-
mally heavily methylated, and it is estimated
that more than one-third of DNA methylation
occurs in repetitive elements, the %5-mC of
repetitive elements can act as a surrogate
marker for percentage of global genomic DNA
methylation (Yang et al. 2004).
Methods
Study population and sample collection and
processing. Blood samples were previously col-
lected from 71 Greenlandic Inuit under the
Arctic Monitoring and Assessment Program
(AMAP), a working group tasked by the
Arctic Council to monitor the levels of pollu-
tants and to assess the effects of pollution in
all compartments of the Arctic environment,
including human populations. The study pop-
ulation and protocol were described previ-
ously (Deutch and Hansen 2000). Briefly,
participants in the study were consecutive
general practice patients recruited by local dis-
trict hospitals during a period of 1–2 months.
Environmental Health Perspectives • VOLUME 116 | NUMBER 11 | November 2008 1547
Research
Address correspondence to J.A. Rusiecki, Department
of Preventive Medicine and Biometrics, PMB Room
A1039, Uniformed Services University of the Health
Sciences, 4301 Jones Bridge Rd., Bethesda, MD
20814–4799 USA. Telephone: (301) 295–3712. Fax:
(301) 295–1854. E-mail: jrusiecki@usuhs.mil
This research was supported by a Uniformed Services
University intramural start-up grant, RO87YT.
The authors declare they have no competing
ﬁnancial interests.
Received 6 February 2008; accepted 16 July 2008.
Global DNA Hypomethylation Is Associated with High Serum-Persistent
Organic Pollutants in Greenlandic Inuit
Jennifer A. Rusiecki,1 Andrea Baccarelli,2 Valentina Bollati,2 Letizia Tarantini,2 Lee E. Moore,3
and Eva C. Bonefeld-Jorgensen4
1Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA;
2Department of Environmental and Occupational Health, University of Milan and IRCCS Maggiore Hospital, Regina Elena and
Mangiagalli, Center of Molecular and Genetic Epidemiology, Milan, Italy; 3Division of Cancer Epidemiology and Genetics, Occupational
and Environmental Epidemiology Branch, National Cancer Institute, National Institutes of Health, Department of Health and Human
Services, Bethesda, Maryland, USA; 4University of Aarhus, Unit of Cellular and Molecular Toxicology, Centre of Arctic Environmental
Medicine, Institute of Public Health, University of Aarhus, Aarhus, Denmark
BACKGROUND: Persistent organic pollutants (POPs) may influence epigenetic mechanisms;
therefore, they could affect chromosomal stability and gene expression. DNA methylation, an epi-
genetic mechanism, has been associated with cancer initiation and progression. Greenlandic Inuit
have some of the highest reported POP levels worldwide. 
OBJECTIVE: Our aim in this study was to evaluate the relationship between plasma POPs concen-
trations and global DNA methylation (percent 5-methylcytosine) in DNA extracted from blood
samples from 70 Greenlandic Inuit. Blood samples were collected under the Arctic Monitoring and
Assessment Program and previously analyzed for a battery of POPs. 
METHODS: We used pyrosequencing to estimate global DNA methylation via Alu and LINE-1 assays
of bisulfite-treated DNA. We investigated correlations between plasma POP concentrations and
global DNA methylation via correlation coefﬁcients and linear regression analyses.
RESULTS: We found inverse correlations between percents methylcytosine and many of the POP
concentrations measured. Linear regressions, adjusting for age and cigarette smoking, showed statis-
tically signiﬁcant inverse linear relationships mainly for the Alu assay for p,p´-DDT (1,1,1-trichloro-
2,2-bis(p-chlorophenyl)ethane; β = –0.26), p,p´-DDE [1,1-dichloro-2,2-bis(p-chlorophenyl)
ethylene; β = –0.38], β-hexachlorocyclohexane (β = –0.48), oxychlordane (β = –0.32), α-chlordane
(β = -0.75), mirex (β = –0.27), sum of polychlorinated biphenyls (β = –0.56), and sum of all POPs
(β = –0.48). Linear regressions for the LINE-1 assay showed β estimates of similar magnitudes to
those using the Alu assay, however, none was statistically signiﬁcant.
CONCLUSIONS: This is the first study to investigate environmental exposure to POPs and DNA
methylation levels in a human population. Global methylation levels were inversely associated with
blood plasma levels for several POPs and merit further investigation.
KEY WORDS: DNA methylation, global methylation, Greenland, hypomethylation, Inuit,
organochlorines, PCBs, persistent organic pollutants, pesticides, polychlorinated biphenyls, POPs,
serum. Environ Health Perspect 116:1547–1552 (2008). doi:10.1289/ehp.11338 available via
http://dx.doi.org/ [Online 16 July 2008]Participants were from various towns through-
out Greenland, representing different geo-
graphical regions: from Scoresbysund (central
east), Tasiilaq (south east), Nanortalik (south
west), Nuuk (south west), Ilulissat (central
sest), and Upernavik (central west). Blood
draws were taken and demographic/lifestyle
data were collected from September 1997 to
April 1998. All participants provided informed
written consent, and the institutional review
boards of the Uniformed Services University
approved the protocol.
Blood samples were collected at the local
district hospitals, separated into plasma and
ETDA whole blood, frozen at –20°C, and
transported to Nuuk, where they were stored
at –80°C until further transport to the
Department of Environmental and Occupa-
tional Medicine, Aarhus University. Using
gas chromatography (GC) as described previ-
ously (Butler Walker et al. 2003) plasma sam-
ples (2 mL) were analyzed at Le Centre de
Toxicologie (Sainte Foy, Quebec, Canada) for
the following POPs: p,p´-DDT [1,1,1-
trichloro-2,2-bis(p-chlorophenyl)ethane],
p,p´-DDE [1,1-dichloro-2,2-bis(p-chloro-
phenyl) ethylene], β-hexachlorocyclohexane
(β-HCH), hexachlorobenzene, chlordane,
cis-chlordane, oxychlordane, α-chlordane,
mirex, toxaphene, and polychlorinated
biphenyl (PCB) congeners 28, 52, 99, 101,
105, 118, 128, 138, 153, 156, 170, 180, 183,
and 187. The methods have been described
previously (Deutch and Hansen 2000). The
recovery of congeners using parallel plasma
samples spiked with 13C- or 14C-PCB standards
was calculated to 98–100%. We determined
plasma lipid levels for total cholesterol (TC),
free cholesterol (FC), triglycerides (TG), and
phospholipids (PL) as well as total lipids using
the following calculation: total lipids = 1.677
(TC – FC) + FC + TG + PL (Patterson et al.
1991). All plasma POPs concentrations were
adjusted for lipids. 
For 70 of the 71 samples, DNA was iso-
lated from EDTA-whole blood at the
University of Aarhus. Cells were lyzed by a
solution of 10% Triton-X, 0.32 M sucrose,
5 nM MgCl2, and 1 mM Tris-HCl (pH 7.5).
After centrifugation at 4,000 rpm (4°C), the
proteins and RNA were cleared away in a solu-
tion of proteinase K (2 mg/mL), 400 mM
NaCl, 2 mM EDTA (pH 8.0), 10 mM Tris-
HCl (pH 7.5), and 5% sodium dodecyl sul-
fate, followed by overnight incubation at 37°C.
Then 27% saturated NaCl was added, mixed
vigorously, and centrifuged at 6,000 rpm for
15 min; the DNA was then isolated from the
supernatant using 96% ethanol at –20°C
overnight. The DNA pellet was resuspended in
200 mL 1 mM Tris-EDTA buffer (pH 8.0)
and stored at 4°C.
Bisulﬁte treatment. We treated 1 µg DNA
(concentration 50 ng/µL) using the EZ DNA
Methylation-Gold Kit (Zymo Research,
Orange, CA, USA) according to the manufac-
turer’s protocol. Final elution was performed
with 30 µL M-Elution Buffer (Zymo
Research). Bisulfite-treated DNA was stored
at –20°C until use.
We used a built-in control to verify bisul-
ﬁte conversion efﬁciency by pyrosequencing:
we used a C outside a CG site. After bisulﬁte
treatment, the conversion of this C into T is
expected to be 100%. It is possible to insert a
C/T single-nucleotide polymorphism into the
sequence to be analyzed that will result in a
100% T if conversion is efﬁcient.
Polymerase chain reaction (PCR) and
pyrosequencing. We quantiﬁed DNA methyla-
tion (%5 mC) using PCR-pyrosequencing of
the bisulfite-treated DNA, as previously
described (Bollati et al. 2007). In brief, the
bisulfite-treated samples were amplified by
PCR. We then used a biotin-labeled primer to
purify the ﬁnal PCR product using Sepharose
beads. The PCR product was bound to
Streptavidin Sepharose HP (Amersham
Biosciences, Uppsala, Sweden), and the
Sepharose beads containing the immobilized
PCR product were purified, washed, and
denatured using a 0.2 M NaOH solution, and
washed again using the Pyrosequencing
Vacuum Prep Tool (Pyrosequencing, Inc.,
Westborough, MA, USA), as recommended
by the manufacturer. Then 0.2 µM pyrose-
quencing primer was annealed to the puriﬁed
single-stranded PCR product and pyrose-
quencing was performed using the PSQ-HS96
Pyrosequencing System (Pyrosequencing,
Inc.). We used Alu and LINE-1 element PCR
for pyrosequencing-based methylation analysis
according to previously published methods
(Yang et al. 2004), with the following modiﬁ-
cations: a 50-µL PCR was carried out in
25-µL GoTaq Green Master mix (Promega,
Madison, WI, USA), 1 pmol of the biotiny-
lated forward primer, 1 pmol of the reverse
primer, 50 ng of bisulfite-treated genomic
DNA, and water.
The percentage of methylation was
expressed for each DNA locus as %5-mC
divided by the sum of methylated and
unmethylated cytosines. We tested each
marker in three replicates and used their aver-
age in the statistical analyses. Some controls
were included in every pyrosequencing run.
To ensure that there was no contamination,
some wells were ﬁlled with water. To be sure
that pyrosequencing was sequencing the cor-
rect pattern, one well was ﬁlled with an oligo-
nucleotide with a known sequence. To
control repeatability of the assay, we filled a
well with fully methylated DNA and a well
with unmethylated DNA.
Statistical analyses. We calculated means
and medians of each POP measured and
mean ± SD %5-mC of Alu and LINE for our
study population and various strata of the
group, using a t-test to evaluate the difference
in %5-mC between males and females,
younger age (19–35 years) and older age
(36–67 years), and smoking (≤ 5 cigarettes/
day, > 5 cigarettes/day).
Using a correlation coefﬁcient (r) for each
LINE-1 and Alu assay, we investigated the rela-
tionships between %5-mC and the lipid-
adjusted concentrations of the tested POPs. We
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Table 1. Serum concentrations (ppb: ng/g-lipid) of POPs measured in 70 Inuit from various geographic
regions of Greenland.
Chemical No. Mean Median Range
p,p’-DDT 70 44.03 25.08 4.04–372.88
p,p’-DDE 70 1624.1 1268.49 264.15–5968.66
β-HCH 70 56.75 39.98 6.25–290.32
Hexachlorobenzene 70 284.49 239.33 39.06–1000
Chlordane 70 1179.03 802.34 86.21–9485.94
cis-Chlordane 61 99.79 83.02 9.09–285.71
Oxychlordane 70 419.5 248.98 29.31–2419.35
α-Chlordane 62 1.69 1.57 1–5.8
Mirex 70 69.89 38.85 3.48–328.36
Toxaphene 70 230.75 193.78 15.91–773.95
PCB-28 70 7.44 5.41 1.14–39.56
PCB-52 70 12.35 8.96 1.06–82.61
PCB-99 70 120.65 92.52 15.38–532.26
PCB-101 70 11.87 8.54 1.28–69.57
PCB-105 70 24.39 13.98 1.82–161.29
PCB-118 70 117.71 78.46 13.64–693.55
PCB-128 70 4.04 2.96 1.12–14.52
PCB-138 70 572.5 412.86 93.59–3064.52
PCB-153 70 1135.78 687.06 152.83–7096.77
PCB-156 70 78.25 54.32 13.21–483.87
PCB-170 70 321.92 137.75 29.31–2419.35
PCB-180 70 697.36 318.43 66.04–5000
PCB-183 70 47.79 38.97 8.82–209.68
PCB-187 70 179.31 140.78 32.08–677.42
ΣPCBs 70 3337.08 1991.06 449.06–20400
ΣPOPs 70 6826.13 4744.10 1035.85–31462.50also used the sum of the 14 PCBs measured
(ΣPCBs) and the sum of all POPs measured
(ΣPOPs). Because the distributions of the
POPs were highly skewed to the right, we cal-
culated a Pearson correlation coefﬁcient using
log-transformed POP concentrations; we also
calculated a Spearman correlation coefﬁcient.
We then carried out linear regression
analyses, modeling each log-transformed POP
concentration on %5-mC. Because both age
(Fraga et al. 2007; Liu et al. 2003) and smok-
ing (Furniss et al. 2008; Smith et al. 2007)
have been found to be associated with global
hypomethylation and because age is strongly
correlated with POP levels, we adjusted for
both as continuous variables (a level of zero
was assigned to nonsmokers). We also
attempted to further investigate potential
effect modification from each of these vari-
ables by stratifying our models by median age
(younger group, 19–35 years; older group,
36–67 years) and smoking level [low: ≤ 5 cig-
arettes/day (zero was included); high: > 5 cig-
arettes/day (range, > 5–35)] and carrying out
a test for interaction. Although there is no
a priori evidence that sex is associated with
global hypomethylation, we wanted to inves-
tigate whether there were differences accord-
ing to sex in our population. As statistical
power was of concern due to the small sample
size of this study, we did not adjust regression
models by sex because the categories were so
unequal. Thus, we carried out linear regres-
sion analyses on the total population (n = 70)
and then stratiﬁed by sex to investigate poten-
tial differences. All statistical tests were two
sided, and analyses were carried out using
SAS software, version 9.1 (SAS Institute Inc.,
Cary, NC, USA).
Results
Among the 70 people included in this study,
61 were male and 9 were females (all females
were from the eastern town of Tasiilaq), and
age ranged from 19 to 67 years. Eleven
(15.7%) of the participants reported that they
never smoked, 18 (25.7%) reported smoking
1–5 cigarettes/day, and 41 (58.6%) reported
smoking 6–35 cigarettes/day. Mean values,
medians, and ranges of each of the POPs
measured are presented in Table 1.
The mean ± SD %5-mC was 25.26 ± 0.84
(range, 23.20–27.30) in the Alu assay and
78.88 ± 2.72 (range, 73.00–84.70) in the
LINE-1 assay (Table 2). For both the Alu and
LINE-1 assays, the distribution was fairly nor-
mal. The average %5-mC did not differ sub-
stantially between younger and older age groups
or between lower- and higher-smoking groups.
We did find a difference, however, when we
applied a t-test for unequal variance between
males and females for both the Alu assay
(p < 0.0001) and the LINE-1 assay (p = 0.02);
males had higher percent methylation than
females. This ﬁnding could be due to the very
small number of females in this study (n = 9),
and therefore the estimate may be imprecise.
Figure 1 presents scatterplots for Alu and
LINE-1 %5-mC versus the log-transformed
ΣPOPs and ΣPCBs, which indicate a negative
linear trend. This was confirmed by the
inverse correlations (r) we found for both
Pearson and Spearman coefficients between
%5-mC and many of the POP (log-trans-
formed) concentrations (i.e., with increasing
concentration of POPs, there was a decreasing
degree of DNA methylation); Table 3 presents
results for the Pearson correlation coefﬁcient
only. The estimates for r for Alu were more
strongly inverse (most in the range of –0.20 to
–0.50) and many of these values were statisti-
cally signiﬁcant compared with those for the
LINE-1 assay, the estimates of which were
generally closer to zero, and none was statisti-
cally significant. Restricting our analyses to
male subjects only yielded similar results to
those carried out for the whole population.
Linear regressions, adjusting for age and
cigarette smoking, showed signiﬁcant inverse
linear relationships, again mainly for the Alu
assay for the following POPs: p,p´-DDT
(β = –0.26, p = 0.01), p,p´-DDE (β = –0.38,
p = 0.01), β-BHC (β = –0.48, p < 0.01), oxy-
chlordane (β = –0.32, p < 0.01), α-chlordane
(β = –0.75, p = 0.05), mirex (β = –0.27,
p = 0.01), sum of PCBs (β = –0.56, p < 0.01;
there were significant inverse linear relation-
ships for all PCB congeners), and sum of all
POPs (β = –0.48, p < 0.01) (Table 4). Results
for linear regressions using the LINE-1 assay
generally showed β estimates of a similar magni-
tude to those using the Alu assay; however, none
was statistically significant. There was a very
strong, marginally significant negative linear
relationship for the LINE-1 assay for β-BHC
(β = –0.98; p = 0.06). When we stratiﬁed the
population into males (n = 61) and females
(n = 9) and ran the linear regressions above, the
β coefﬁcients did not differ substantially.
We stratiﬁed by younger age and older age
and by low smoking and high smoking. We
found negative linear relationships between
POPs and percent methylation for each of the
age strata and smoking strata; however, the
estimates were more strongly negative and
statistically signiﬁcant for the Alu assay (data
Global DNA hypomethylation associated with serum POPs
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Table 2. Percent global DNA methylation (5-mC%) in Alu and LINE-1 markers in Greenlandic Inuit, whole
population and various characteristics.
Alu assay LINE-1 assay
Characteristic No. Mean SD p-Valuea Mean SD p-Valuea
Whole population 70 25.26 0.84 78.88 2.72
Sex
Male 61 25.35 0.86 79.05 2.85
Female 9 24.69 0.06 < 0.0001 77.73 1.18 0.02
Age group (years)
Younger (19–35) 35 25.18 0.83 78.68 2.92
Older (36–67) 35 25.34 0.84 0.44 79.09 2.53 0.53
Smoking
Low (≤ 5 cigarettes/day)b 29 25.22 0.83 79.10 2.75
High (> 5 cigarettes/day) 41 25.29 0.85 0.76 78.73 2.72 0.59
at-test to examine differences in Alu and LINE for males vs. females, younger age vs. older age, and low vs. high smoking.
bIncludes 0 cigarettes/day. 
Figure 1. Linear plots of %5-mC, based on Alu and LINE-1, versus the natural log of ΣPOPs and ΣPCBs.
(A) Alu versus ln(ΣPOPs). (B) LINE-1 versus ln(ΣPOPs). (C) Alu versus ln(ΣPCBs). (D) LINE-1 versus
ln(ΣPCBs). 
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Anot shown). We found no significant differ-
ences in the linear relationships between
younger and older age groups and between low
smoking and high smoking groups. Tests for
interaction also indicated that neither of these
variables is an effect modiﬁer.
To investigate our ﬁndings further, we cat-
egorized each individual POP into tertiles and
carried out linear regression analyses, compar-
ing the second and third tertiles to the ﬁrst ter-
tile. The results from this analysis conﬁrmed
our findings of an inverse linear relationship
(i.e., as found for the POPs in the model as a
continuous variable), in that the β coefﬁcient
for the third tertile was more strongly inverse
than the β coefﬁcient for the second tertile. For
most POPs, estimates in the third tertile were
statistically signiﬁcant for the Alu assay but not
the for the LINE-1 assay (data not shown)
Discussion
In vitro and animal studies have suggested that
exposure to endocrine disruptors, such as
POPs, may adversely affect DNA methylation
patterns (Anway et al. 2006; Anway and
Skinner 2006; Chang et al. 2006; Kang and
Lee 2005). To our knowledge, this had not
previously been investigated in a human
population. We observed a consistent inverse
correlation and linear relationship between
POPs levels and percent methylation of Alu
and LINE-1 repetitive elements, though the
results were more marked and statistically sig-
niﬁcant for the Alu assay. LINE-1 and Alu are
controlled through different mechanisms
(Gonzalgo and Jones 1997) and have different
transcription patterns in response to cellular
stressors (Li and Schmid 2001), so this could
account for the differences we saw in magni-
tude and signiﬁcance of correlations. We used
DNA methylation analyses of Alu and LINE-1
repetitive elements to evaluate global methyla-
tion. Due to the heavy methylation of repeti-
tive elements, these assays, which are easier to
carry out than previous methods used to
quantify total genomic 5-mC, can detect
decreases in DNA methylation and serve as a
surrogate for global methylation (Yang et al.
2004). Our results suggest that global hypo-
methylation is associated with high levels of
environmental exposure to POPs. We must
consider that the POPs investigated here are
all correlated with each other, so it is not sur-
prising that our ﬁndings of inverse correlations
are consistent across POPs.
Compared to other populations described
in a recent study (Rusiecki et al. 2005), the
POP levels detected in this population are rel-
atively high. For the organochlorine pesticides,
such as p,p´-DDT, its metabolite p,p´-DDE,
and β-HCH, the plasma levels observed in
this population rank among the highest in the
world. For individual PCB congeners, such as
PCB-153 and PCB-180, the levels are compa-
rable to those from another study among Inuit
living in Nunavik, Canada (AMAP 2003;
Ayotte et al. 1997). However, our study popu-
lation is also characterized by a variation in
concentrations, enabling us to fully investigate
DNA methylation across a wide range.
We considered age an important con-
founder to control, because it is strongly corre-
lated with serum POP concentrations and
because epigenetic alterations, including global
hypomethylation, can be progressively accu-
mulated during aging and directly contribute
Rusiecki et al.
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Table 3. Pearson correlation coefficients (r) for %5-mC and POPs concentrations (log-transformed) in
serum from 70 Greenlandic Inuit.
Mean Alu Mean LINE-1 
Chemical rp -Value rp -Value
p,p´-DDT –0.23 0.06 0.04 0.74
p,p´-DDE –0.17 0.15 0.04 0.75
β-HCH –0.19 0.11 –0.13 0.30
Hexachlorobenzene 0.15 0.20 –0.07 0.55
Chlordane –0.04 0.73 –0.06 0.63
cis-Chlordane 0.10 0.43 0.00 0.99
Oxychlordane –0.15 0.22 –0.12 0.33
α-Chlordane –0.26 0.04* –0.08 0.56
Mirex –0.17 0.17 –0.03 0.82
Toxaphene 0.17 0.16 0.01 0.96
PCB-28 –0.22 0.07 –0.08 0.48
PCB-52 –0.07 0.59 0.00 0.98
PCB-99 –0.31 0.01* –0.09 0.44
PCB-101 –0.15 0.20 0.11 0.35
PCB-105 –0.32 0.01* –0.14 0.26
PCB-118 –0.23 0.05* –0.11 0.37
PCB-128 –0.32 0.01* 0.02 0.88
PCB-138 –0.31 0.01* –0.08 0.51
PCB-153 –0.38 < 0.01* –0.09 0.44
PCB-156 –0.35 < 0.01* –0.06 0.59
PCB-170 –0.49 < 0.01* –0.12 0.32
PCB-180 –0.43 < 0.01* –0.09 0.48
PCB-183 –0.35 < 0.01* –0.01 0.95
PCB-187 –0.21 0.08 0.02 0.89
ΣPCBs –0.38 < 0.01* –0.08 0.49
ΣPOPs –0.25 0.04* –0.06 0.64
*Estimate is statistically signiﬁcant at α≤0.05. 
Table 4. Results for linear regressions, adjusted for age and smoking, of POP concentrations (log-
transformed) on %5-mC.a
Alu LINE-1
Chemical β-Estimate p-Value β-Estimate p-Value
DDT –0.26 0.01* 0.06 0.87
DDE –0.38 0.01* –0.02 0.97
β-HCH –0.48 < 0.01* –0.90 0.09
Hexachlorobenzene 0.06 0.72 –0.72 0.19
Chlordane –0.21 0.11 –0.46 0.27
cis-Chlordane 0.02 0.91 –0.01 0.99
Oxychlordane –0.32 < 0.01* –0.66 0.09
α-Chlordane –0.75 0.05* –0.62 0.60
Mirex –0.27 0.01* –0.23 0.51
Toxaphene 0.09 0.51 –0.16 0.72
PCB-28 –0.42 < 0.01* –0.55 0.23
PCB-52 –0.12 0.36 –0.05 0.91
PCB-99 –0.51 < 0.01* –0.55 0.22
PCB-101 –0.25 0.05* 0.33 0.44
PCB-105 –0.51 < 0.01* –0.71 0.08
PCB-118 –0.49 < 0.01* –0.73 0.12
PCB-128 –0.52 < 0.01* –0.01 0.99
PCB-138 –0.54 < 0.01* –0.52 0.24
PCB-153 –0.52 < 0.01* –0.47 0.22
PCB-156 –0.66 < 0.01* –0.48 0.26
PCB-170 –0.54 < 0.01* –0.48 0.15
PCB-180 –0.54 < 0.01* –0.43 0.24
PCB-183 –0.57 < 0.01* –0.20 0.67
PCB-187 –0.49 < 0.01* –0.15 0.77
ΣPCBs –0.56 < 0.01* –0.49 0.23
ΣPOPs –0.48 < 0.01* –0.46 0.32
aAge variable was continuous; smoking variable was continuous, reﬂecting number of cigarettes per day (or zero if a non-
smoker). *Estimate is statistically signiﬁcant at α≤0.05.to cell transformation (Fraga et al. 2007). In
the present study, we detected the typical pat-
tern of a positive correlation between age and
almost all POPs we investigated (r values
ranged from 0.22 to 0.65 and all were statisti-
cally signiﬁcant at p ≤ 0.05). Despite the wide
age range (19–67 years), which could reduce
statistical power, and although the correlation
between age and degree of DNA methylation
using the Alu (r = 0.05, p = 0.60) and LINE-1
(r = 0.03, p = 0.75) assays was nonsigniﬁcant,
we adjusted for age in our models and carried
out stratified analyses by age. We made this
adjustment because of a priori evidence of an
association with both %5-mC and with POPs
(Fraga et al. 2007). Smoking is also important
to consider because it has been associated with
a state of hypomethylation in various cancers
(Furniss et al. 2008; Smith et al. 2007), so we
included it in our final models, despite our
t-tests not showing a difference in %5-mC
between the two smoking groups. Similar to
age, stratified analyses did not reveal differ-
ences between the two smoking groups. For
neither age nor smoking did we ﬁnd statisti-
cally significant interactions; however, our
power was limited based on the small sample
size of the study, especially after stratiﬁcation,
so we were limited in our ability to evaluate
interaction. Regarding sex, although we found
a significant difference between males and
females with respect to %5-mC for both the
Alu and LINE-1 assays, we did not ﬁnd that
the association between DNA methylation
and POPs differed when we stratified linear
regression analyses on sex. Again, we were
likely inhibited in our ability to fully examine
a potential sex difference because of the small
sample size of the overall population and
because there were only nine women included.
The biologic mechanism for POPs inter-
fering with DNA methylation is unclear.
Many of these POPs behave as endocrine dis-
ruptors, which may promote an alteration in
DNA methylation sequences; this is associ-
ated with the development of transgenera-
tional disease states (Chang et al. 2006).
Recently, two endocrine disruptors, methoxy-
chlor and vinclozolin, were shown to alter the
spermatogenic capacity of male germ cells and
sperm viability via their effects on DNA
methylation (Anway and Skinner 2006; Tabb
and Blumberg 2006). Another recent study
found that MCF7 cells treated with butyl
benzylphthalate, an endocrine disruptor due
to its antiandrogenic or proestrogenic effects,
altered estrogen receptor (ER) mRNA expres-
sion, and this may be related to aberrant
DNA methylation in the promoter region of
ER (Kang and Lee 2005).
Because of the cross sectional nature of the
study, we were unable to determine if POP
exposure leads to an aberrant global methyla-
tion status. In addition, in spite of the strong
negative correlations and linear relationships,
we cannot exclude that other contaminants
ubiquitous in the Arctic environment, such as
heavy metals (mercury, cadmium, lead) and
radioactive elements (AMAP 2002) may have
contributed to these ﬁndings. We did not have
detailed smoking data, only the number of cig-
arettes smoked per day, which thus decreased
our ability to evaluate smoking as an effect
modifier. Another limitation of this study is
that we did not have detailed dietary informa-
tion, which could shed light on the accumula-
tion of POP body burden over time and also
could be important regarding folate intake.
Folate plays an important role in DNA methy-
lation: It is required for the synthesis of
S-adenosyl methionine, the common methyl
donor required for the maintenance of methy-
lation patterns in DNA (Brunaud et al. 2003).
Folate also plays a critical role in the preven-
tion of chromosomal breakage and hypo-
methylation of DNA (Fenech 2001; Pyathilake
and Johanning 2002). We carried out multiple
comparisons in this study; however, because
the majority of POPs showed a statistically sig-
niﬁcant inverse linear relationship in the Alu
assay, our focus was on the detected pattern of
association between degree of global methyla-
tion and lifetime POP body burden, rather
than an association found for a speciﬁc POP.
A major strength of our study is that meas-
urement of percent DNA methylation was
based on a quantitative analysis using pyrose-
quencing methodology, which is highly repro-
ducible and accurate for measuring small
changes in DNA methylation. Epigenetic
changes from environmental exposures or
those occurring in the early stages of a disease
such as cancer may not be as dramatic as those
occurring in later stages; thus a quantitative
measure of DNA methylation may be the only
tool sensitive enough to elucidate such
changes. Additionally, using pyrosequencing
to quantify %5-mC enabled us to have a
built-in quality control for bisulﬁte treatment
(Dupont et al. 2004). The bisulﬁte treatment
control is dependent on the fact that any
cytosines not within a CpG site should be
fully converted to thymines because these
cytosines are not methylated. If the bisulfite
treatment is not complete, the pyrosequencing
reaction can detect the ratio of thymines to
cytosines, thus indicating the efficiency of
bisulfite treatment. Similarly, the ratio of
thymines to cytosines at a particular CpG site
after bisulﬁte treatment and PCR indicates the
degree of methylation.
The present study shows for the ﬁrst time
that there is a relatively strong correlation
between increasing serum levels of POPs and
global DNA hypomethylation, which is an
aberrant epigenetic pattern in malignant cells.
These results support the hypothesis that expo-
sure to potentially carcinogenic compounds
such as POPs may influence DNA methyla-
tion. Our study was characterized by quanti-
tative, biologic exposure assessment of
lipid-adjusted, lifetime POP body burden in a
population with some of the highest levels in
the world and a highly reproducible, high
throughput method to measure percent DNA
methylation. The ﬁndings from this study are
intriguing and merit further investigation. 
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